These findings provide a new theoretical foundation for understanding the role of TMSB10 in the progression of prostate cancer and have significant scientific and clinical implications for the development of new therapeutic targets and for improving the clinical prognosis of prostate cancer patients. The gene discussed is TMSB10; the disease is prostate carcinoma.